Clinical Trial Update: FOLFOXIRI Compared With FOLFIRI for Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing FOLFOXIRI to FOLFIRI for metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• FOLFIRI (irinotecan, leucovorin, 5-fluorouracil)
• FOLFOXIRI (folinic acid (leucovorin), fluorouracil (5-FU), oxaliplatin, irinotecan)

Snippet

Sponsor: Gruppo Oncologico del Nord-Ovest | Conditions: Metastatic Colorectal Cancer | Phase 3 | Status: COMPLETED